Related Experiment Video

Updated: Apr 18, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.6K

Genetics and nonmelanoma skin cancer in kidney transplant recipients

Michael T Burke1, Nicole Isbel, Katherine A Barraclough

  • 1Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, Australia.

Pharmacogenomics
|January 24, 2015
PubMed

Insights

Kidney transplant recipients face a significantly higher risk of nonmelanoma skin cancer due to immunosuppression and UV exposure. Genetic variations in key enzymes and receptors may further elevate this risk, suggesting personalized screening and treatment strategies.

Area of Science:

  • Transplant medicine
  • Dermatology
  • Pharmacogenomics

Background:

  • Kidney transplant recipients (KTRs) exhibit a 65- to 250-fold increased incidence of nonmelanoma skin cancer compared to the general population.
  • Key modifiable risk factors include immunosuppressive drug regimens and ultraviolet (UV) radiation exposure.
  • Genetic variations influencing drug metabolism and response are implicated in transplant complications and may impact skin cancer risk.

Purpose of the Study:

  • To investigate the association between genetic polymorphisms and nonmelanoma skin cancer risk in KTRs.
  • To explore how genetic variations in drug-related genes may contribute to differential skin cancer rates among KTRs.
  • To identify potential genetic markers for guiding immunosuppressive therapy and skin cancer surveillance in KTRs.

Main Methods:

  • Review of genetic association studies examining polymorphisms in relevant genes.
  • Analysis of genes including those encoding the prednisolone receptor, GST enzyme, MC1R, MTHFR enzyme, and COX-2 enzyme.
  • Correlation of identified genetic variations with nonmelanoma skin cancer development in KTR cohorts.

Main Results:

  • Specific genetic polymorphisms in the prednisolone receptor, GST, MC1R, MTHFR, and COX-2 genes are linked to increased nonmelanoma skin cancer risk in KTRs.
  • These genetic variations may influence the pharmacokinetics and pharmacodynamics of immunosuppressive drugs, thereby affecting cancer risk.
  • Evidence suggests a role for genetic predisposition in the heightened skin cancer susceptibility observed in this patient group.

Conclusions:

  • Genetic variations play a significant role in determining nonmelanoma skin cancer risk among kidney transplant recipients.
  • Understanding these genetic factors can enhance risk stratification and inform personalized approaches to immunosuppression and cancer screening.
  • Further genetic association studies are warranted to elucidate mechanisms and optimize patient management.
Keywords:
geneticsimmunosuppressionnonmelanoma skin cancerpharmacogeneticsrenal transplantskin cancer

More Related Videos

Murine Full-thickness Skin Transplantation07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

21.8K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.8K

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
784
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
872
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.7K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
605
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.8K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.3K